These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33403393)

  • 41. Epidemiology of rabies cases among international travellers, 2013-2019: A retrospective analysis of published reports.
    Gautret P; Diaz-Menendez M; Goorhuis A; Wallace RM; Msimang V; Blanton J; Dacheux L; Parize P; Blumberg L; Bourhy H; Grobusch MP
    Travel Med Infect Dis; 2020; 36():101766. PubMed ID: 32525075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rabies post-exposure prophylaxis of overseas travelers in the international travel clinic of the national medical center from 2006 to 2012, Korea.
    Park JH; Lee CH; Won YK; Chin BS; Shin HS; Kim JY
    Infect Chemother; 2014 Mar; 46(1):13-20. PubMed ID: 24693465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Awareness about rabies post exposure prophylaxis in Pakistan among patients and health care workers: results from an Asian Rabies Expert Bureau study.
    Salahuddin N; Jamali S; Ibraheem K; Sardar S
    J Coll Physicians Surg Pak; 2011 Aug; 21(8):491-4. PubMed ID: 21798137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human rabies post-exposure prophylaxis relative to the disease epidemiological status.
    Andrade BFMDC; Andrade TSM; Queiroz LH
    Cien Saude Colet; 2019 Jan; 24(1):315-322. PubMed ID: 30698264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overview of rabies post-exposure prophylaxis access, procurement and distribution in selected countries in Asia and Africa, 2017-2018.
    Sreenivasan N; Li A; Shiferaw M; Tran CH; Wallace R; Blanton J; Knopf L; Abela-Ridder B; Hyde T;
    Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A6-A13. PubMed ID: 31471150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How geographic access to care shapes disease burden: The current impact of post-exposure prophylaxis and potential for expanded access to prevent human rabies deaths in Madagascar.
    Rajeev M; Guis H; Edosoa GT; Hanitriniaina C; Randrianarijaona A; Mangahasimbola RT; Hierink F; Ramiandrasoa R; Nely J; Heraud JM; Andriamandimby SF; Baril L; Metcalf CJE; Hampson K
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0008821. PubMed ID: 33901194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenicity and 1-year boostability of a three-dose intramuscular rabies pre-exposure prophylaxis schedule in adults receiving immunosuppressive monotherapy: a prospective single-centre clinical trial.
    Garcia Garrido HM; van Put B; Terryn S; de Pijper CA; Stijnis C; D'Haens GR; Spuls PI; van de Sande MG; van Gucht S; Grobusch MP; Goorhuis A
    J Travel Med; 2023 Apr; 30(2):. PubMed ID: 36477981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health economic assessment of a rabies pre-exposure prophylaxis program compared with post-exposure prophylaxis alone in high-risk age groups in the Philippines.
    Quiambao B; Varghese L; Demarteau N; Sengson RF; Javier J; Mukherjee P; Manio LC; Preiss S
    Int J Infect Dis; 2020 Aug; 97():38-46. PubMed ID: 32450291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Animal bite and rabies postexposure prophylaxis reporting--United States, 2013.
    Vora NM; Clippard JR; Stobierski MG; Signs K; Blanton JD
    J Public Health Manag Pract; 2015; 21(3):E24-7. PubMed ID: 25084537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Discontinuation of postexposure prophylaxis at the anti-rabies Center of Abidjan, Côte d'Ivoire].
    Tiembre I; Benie J; Attoh-Touré H; Zengbe-Acray P; Tetchi SM; Kpebo D; Lezou AP; Dagnan S
    Bull Soc Pathol Exot; 2013 Oct; 106(4):272-7. PubMed ID: 24136660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Thai Red Cross protocol experience in Côte d'Ivoire.
    Tetchi M; Coulibaly M; Kallo V; Traoré GS; Issaka T; Joseph B; Gerber F; Lechenne M; Zinsstag J; Bonfoh B
    Acta Trop; 2020 Dec; 212():105710. PubMed ID: 32941800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determinants of health seeking behavior of animal bite victims in rabies endemic South Bhutan: a community-based contact-tracing survey.
    Penjor K; Tenzin T; Jamtsho RK
    BMC Public Health; 2019 Feb; 19(1):237. PubMed ID: 30813935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rabies vaccination for international travelers.
    Gautret P; Parola P
    Vaccine; 2012 Jan; 30(2):126-33. PubMed ID: 22085557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rabies vaccine initiation and adherence among animal-bite patients in Haiti, 2015.
    Tran CH; Kligerman M; Andrecy LL; Etheart MD; Adrien P; Blanton JD; Millien M; Wallace RM
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006955. PubMed ID: 30422986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of rabies post-exposure prophylaxis in the context of very low rabies risk: A decision-tree model based on the experience of France.
    Ribadeau Dumas F; N'Diaye DS; Paireau J; Gautret P; Bourhy H; Le Pen C; Yazdanpanah Y
    Vaccine; 2015 May; 33(20):2367-78. PubMed ID: 25797366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intradermal rabies pre-exposure vaccination schedules in older travellers: comparison of immunogenicity post-primary course and post-booster.
    Furuya-Kanamori L; Ramsey L; Manson M; Gilbert B; Lau CL
    J Travel Med; 2020 Nov; 27(7):. PubMed ID: 31943042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre-exposure rabies prophylaxis for the international traveller: a decision analysis.
    LeGuerrier P; Pilon PA; Deshaies D; Allard R
    Vaccine; 1996 Feb; 14(2):167-76. PubMed ID: 8852415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis.
    Tantawichien T; Sibunruang S; Tantawichien T; Angsanakul J; Benjavongkulchai M; Limsuwan K; Udomchaisakul P; Khomvilai S; Sitprija V
    Expert Rev Vaccines; 2014 Dec; 13(12):1593-601. PubMed ID: 25315021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of risk factors for rabies exposure and access to post-exposure prophylaxis in Chad.
    Madjadinan A; Hattendorf J; Mindekem R; Mbaipago N; Moyengar R; Gerber F; Oussiguéré A; Naissengar K; Zinsstag J; Lechenne M
    Acta Trop; 2020 Sep; 209():105484. PubMed ID: 32304698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Descriptive assessment of rabies post-exposure prophylaxis procurement, distribution, monitoring, and reporting in four Asian countries: Bangladesh, Bhutan, Cambodia, and Sri Lanka, 2017-2018.
    Li AJ; Sreenivasan N; Siddiqi UR; Tahmina S; Penjor K; Sovann L; Gunesekera A; Blanton JD; Knopf L; Hyde TB
    Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A14-A19. PubMed ID: 30314908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.